Sartorius | SRT3 - Nettoeinkommen

Aktienkurs
217.10
Täglich Wechseln
2.20 1.02%
Monatlich
0.74%
Jährlich
-3.12%
Q2 Prognose
211.39




Nettoeinkommen Veränderung Datum
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
Avita Medical AUD -11.62M 1.7M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Moderna USD -200M 625M 2025-09
Organon & Co USD 160M 15M 2025-09
Revvity USD 98.36M 51.71M 2025-12
Sartorius EUR 56.2M 37M 2026-03
Tectonic Therapeutic USD -19.23M 186K 2025-12
Viatris USD -340.1M 211.9M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12